Tech

A metal composite that will float your boat

Researchers have demonstrated a new metal matrix composite that is so light that it can float on water. A boat made of such lightweight composites will not sink despite damage to its structure. The new material also promises to improve automotive fuel economy because it combines light weight with heat resistance.

Although syntactic foams have been around for many years, this is the first development of a lightweight metal matrix syntactic foam. It is the work of a team of researchers from Deep Springs Technology (DST) and the New York University Polytechnic School of Engineering.

New photocathode with artificial photosynthesis potential

Many of us are familiar with electrolytic splitting of water from their school days: if you hold two electrodes into an aqueous electrolyte and apply a sufficient voltage, gas bubbles of hydrogen and oxygen are formed. If this voltage is generated by sunlight in a solar cell, then you could store solar energy by generating hydrogen gas.This is because hydrogen is a versatile medium of storing and using "chemical energy".

Bone tissue regenerated using only proteins secreted by stem cells

Scientists have discovered a way to regrow bone tissue using the protein signals produced by stem cells. This technology could help treat victims who have experienced major trauma to a limb, like soldiers wounded in combat or casualties of a natural disaster. The new method improves on older therapies by providing a sustainable source for fresh tissue and reducing the risk of tumor formation that can arise with stem cell transplants.

80 percent of cervical cancers preventable with 9-valent HPV vaccine

The new 9-valent human papillomavirus vaccine, can potentially prevent 80 percent of cervical cancers in the United States, if given to all 11- or 12-year-old children before they are exposed to the virus.

Rise of the Robot pets

University of Melbourne animal welfare researcher Dr Jean-Loup Rault says the prospect of robopets and virtual pets is not as far-fetched as we may think.

His paper in the latest edition of Frontiers in Veterinary Science argues pets will soon become a luxury in an overpopulated world and the future may lie in chips and circuits that mimic the real thing.

"It might sound surreal for us to have robotic or virtual pets, but it could be totally normal for the next generation," Dr Rault said.

Cancer-specific gene therapy eradicates prostate cancer in experiments

Even with the best available treatments, the median survival of patients with metastatic, hormone-refractory prostate cancer is only two to three years. Driven by the need for more effective therapies for these patients, researchers at VCU Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a unique approach that uses microscopic gas bubbles to deliver directly to the cancer a viral gene therapy in combination with an experimental drug that targets a specific gene driving the cancer's growth.

CRISPR genome editing is transforming medicine, nutrition, and agriculture

Researchers have customized and refined a technique derived from the immune system of bacteria to develop the CRISPR-Cas9 genome engineering system, which enables targeted modifications to the genes of virtually any organism.

The discovery and development of CRISPR-Cas9 technology, its wide range of potential applications in the agriculture/food industry and in modern medicine, and emerging regulatory issues are explored in a Review article published in OMICS: A Journal of Integrative Biology.

Anti-cancer drugs: New combination treatment strategy to 'checkmate' glioblastoma

Therapies that specifically target mutations in a person's cancer have been much-heralded in recent years, yet cancer cells often find a way around them. To address this, researchers at University of California, San Diego School of Medicine and Moores Cancer Center identified a promising combinatorial approach to treating glioblastomas, the most common form of primary brain cancer.

Engineering bacteria to design vaccines

The EU-funded MycoSynVac project combines gene engineering and biotechnology to design a novel veterinary vaccine chassis based on the bacterium Mycoplasma pneumoniae.

Scene recognition and what it means for how computers will see objects

Object recognition - determining what objects are where in a digital image - is a central research topic in computer vision but a person looking at an image will spontaneously make a higher-level judgment about the scene as whole: It's a kitchen, or a campsite, or a conference room. Among computer science researchers, the problem known as "scene recognition" has received relatively little attention.

MIT engineers hand 'cognitive' control to underwater robots

For the last decade, scientists have deployed increasingly capable underwater robots to map and monitor pockets of the ocean to track the health of fisheries, and survey marine habitats and species. In general, such robots are effective at carrying out low-level tasks, specifically assigned to them by human engineers -- a tedious and time-consuming process for the engineers.

Chagas disease vaccine shows long-term protection in mice

Chagas disease, caused by the Trypanosoma cruzi parasite and transmitted by insects in Latin America is among the most common tropical diseases, and so far without effective vaccine. A study published on May 7th in PLOS Pathogens now shows that a candidate vaccine can induce long-lasting immunity against the parasite in mice.

This artificial pancreas just made giving birth safer for diabetic women

Last week, a British diabetic women became the world’s first to complete a natural vaginal birth using an artificial pancreas. This news is a big step forward for all mothers with diabetes.

3-D 'organoids' grown from patient tumors could personalize drug screening

Three-dimensional cultures (or "organoids") derived from the tumors of cancer patients closely replicate key properties of the original tumors, reveals a study published May 7 in Cell. These "organoid" cultures are amenable to large-scale drug screens for the detection of genetic changes associated with drug sensitivity and pave the way for personalized treatment approaches that could optimize clinical outcomes in cancer patients.

Nuclear medicine could identify who benefits from aromatase inhibitor treatment

A new, noninvasive nuclear medicine test can be used to determine whether aromatase inhibitor treatment will be effective for specific cancer patients, according to a recent study reported in The Journal of Nuclear Medicine. The research shows that a PET scan with the ligand C-11-vorozole reliably detects aromatase in all body organs - demonstrating the value of its future use to pre-determine the effectiveness of the treatment for breast, ovarian, endometrial and lung cancer patients, potentially reducing unnecessary treatment costs and adverse effects.